Consequently, our results have significant clinical implications, suggesting SIX1 as a potential candidate gene for individuals with non-syndromic hearing loss (DFNA23) and/or preauricular fistula, even without the typical BOR/BO syndrome features. This evidence concerns the gene SIX1 and BOR syndrome.